MedTrace Logo

Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis

NCT06180551 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-12-22

No results posted yet for this study

Summary

Critically ill patients are at risk of developing a sudden decrease of kidney function which may be detected by a decrease in urine output or is diagnosed on the basis of blood tests for substances normally eliminated by the kidney, primarily creatinine.

Because it takes about 24 hours for the creatinine level to rise, even if both kidneys have ceased to function, better markers are needed.

This trial is investigating if the marker urinary dickkopf-3 (uDKK3) allows an early prediction of a sudden decrease of kidney function.

Conditions

Interventions

DIAGNOSTIC_TEST

DKK-3

DKK-3-Urine measurement

Sponsors & Collaborators

  • Universität des Saarlandes

    lead OTHER

Principal Investigators

  • Stefan Neuhaus, MD · Universität des Saarlandes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180551 on ClinicalTrials.gov